Simply Wall St.3d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Rally Already Priced In?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey73d agoneutral
New FDA Approval Gives Bristol-Myers Squibb (BMY) Another Potential Oncology Growth CatalystSimply Wall St.85d agoneutral
Bristol Myers Squibb (BMY) Stock May Be 46% Undervalued As FDA Approval LandsSimply Wall St.86d agobullish
Bristol Myers Squibb (BMY) Wins FDA Approval, Is The Stock Fully Priced?BioPharma Dive86d agobullish
Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene